3,5-Diamino-6-chloro-pyrazine-2-carbox ylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of arway diseases

Details for Australian Patent Application No. 2009248179 (hide)

Owner Novartis AG

Inventors Hunt, Thomas Anthony; Collingwood, Stephen Paul; Howsham, Catherine

Agent Davies Collison Cave

Pub. Number AU-A-2009248179

PCT Pub. Number WO2009/138378

Priority 08156060.9 13.05.08 EP

Filing date 11 May 2009

Wipo publication date 19 November 2009

International Classifications

C07D 241/28 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

A61K 31/497 (2006.01)

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

2 December 2010 PCT application entered the National Phase

  PCT publication WO2009/138378 Priority application(s): WO2009/138378

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009248184-Polyamide emulsifier based on polyamines and fatty acid/carboxylic acid for oil based drilling fluid applications

2009248177-3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor